In this case report, Boer et al. describe the treatment of a Dutch patient with tetanus infection and illustrate the role of benzodiazepines as well as other key aspects of treating patients with tetanus. Click here to read more.
Featured Article - The need to increase antimicrobial resistance surveillance among forcibly displaced persons (FDPs)
Articles
-
-
Trend of pulmonary tuberculosis and rifampicin-resistance among tuberculosis presumptive patients in Central Tigray, Ethiopia; 2018 -2023: a six-year retrospective study
-
Exploring the utilization and perceptions of pre-travel health consultations in primary care settings in Saudi Arabia: a cross-sectional study
-
Tetanus– a case report highlighting the challenges in diagnosis and treatment
-
Blood smears examination and prevalence of malaria in Addis Zemen Town, Northwest Ethiopia (2013–2021): a retrospective study
-
Reactive arthritis in the right hip following COVID-19 infection: a case report
-
COVID-19 in comparison with other emerging viral diseases: risk of geographic spread via travel
-
More harm than good? The questionable ethics of medical volunteering and international student placements
-
Travel medicine, coca and cocaine: demystifying and rehabilitating Erythroxylum – a comprehensive review
-
Sun, sea and sex: a review of the sex tourism literature
Call for Papers
Intoxications and Environmental Insults of Travel is open for submissions.
This series explores the many ways in which non-pathogen based exposures and intoxications can affect travelers, and explore the global epidemiology of such disease risks.
Article Collection: Parasitic Diseases and Immunosuppression
This series entitled Parasitic Diseases and Immunosuppression aims to better illuminate the underpinnings of host-parasite interactions, and to strive towards not just treating but preventing the attributable clinical fallout.
Aims and scope
Editor in Chief - Dr Marco Goeijenbier
Dr. Marco Goeijenbier graduated from the University of Amsterdam with a medical degree in 2010, followed by a degree in biomedical science from Erasmus University Rotterdam in 2012. He completed his PhD in virology, focusing on "Haemostasis and Virus Infection," at Erasmus University Rotterdam in 2015.
He currently serves as a specialist in acute internal medicine and critical care at Spaarne Hospital in Haarlem, the Netherlands. His expertise spans various aspects of infectious diseases, particularly in critical care medicine and viral infections.
In addition to his clinical work, Dr. Goeijenbier holds a research position at Erasmus MC in Rotterdam, where he mentors PhD students exploring critical care medicine and viral infections. His research interests focus on severe acute respiratory infection (SARI) pathogenesis, epidemiology, and their interaction with the coagulation system.
Dr. Goeijenbier is the Chair of the Influenza Diabetes Community (IDC). The IDC connects leading diabetes, patient, scientific and professional organisations around the common aim of protecting persons living with diabetes from influenza and other viral respiratory diseases like COVID-19. Starting January 2023, Dr. Goeijenbier also took on the role of Chair of Medical Research and Education at Spaarne Hospital.
Annual Journal Metrics
-
Citation Impact 2023
Journal Impact Factor: 2.4
5-year Journal Impact Factor: 2.5
Source Normalized Impact per Paper (SNIP): 0.858
SCImago Journal Rank (SJR): 0.708Speed 2023
Submission to first editorial decision (median days): 8
Submission to acceptance (median days): 115Usage 2023
Downloads: 312,456
Altmetric mentions: 262